| | | CHICAGO (Reuters) - Memo from the Internal Revenue Service to retirement investors: Be careful with those individual retirement account rollovers. | | | | NEW YORK (Reuters) - Fidelity Investments and BlackRock Inc, already partners in the exchange-traded funds market, are teaming up once again to launch a new ETF-heavy managed account aimed at providing income for investors preparing for retirement. | | | | | | | LONG BEACH, California (Reuters) - You've been on offense with your global stock portfolio for five years, running up the score in sectors like consumer discretionary and technology stocks that have outperformed the broad market. | | | | | | | NEW YORK (Reuters) - Ever since they were badly burned in the 2008-2009 stock and bond debacle, investors have been pouring money into so-called "alternative" mutual funds, often at the behest of financial advisers who say those funds will protect them from the fire next time. | | | | | (Reuters) - U.S. retirement savers are increasingly diversifying into international equities, but are still leaving much of what has to be considered a free lunch on the table. | | | | | NEW YORK (Reuters) - My family's contribution to the $15 billion annual allergy business tallies up to well over $100 a month, but our costs - like many people's - are adding up differently this year. | | | | | NEW YORK (Reuters) - William Ackman's $47 billion joint bid with Valeant Pharmaceuticals International Inc to buy Botox maker Allergan Inc may become a model for future deals, rival fund managers said. | | | | | BOSTON (Reuters) - Shares of Janus Capital Group Inc rose on Tuesday after the Denver asset manager reported reduced withdrawals of cash by investors. | | | | | | ORLANDO, Florida (Reuters) - The conservative advocacy groups backed by the billionaire brothers Charles and David Koch are known mostly for spending millions of dollars to pelt Democratic candidates with negative television ads. | | | | | | | BOSTON/NEW YORK (Reuters) - Activist investor William Ackman teamed up with Canadian drugmaker Valeant Pharmaceuticals International Inc to make a joint run at buying wrinkle-treatment maker Allergan Inc, according to security filings on Monday. | | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment